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To determine human herpesvirus 8 (HHV-8) K1 geno-
types in patients with Kaposi sarcoma (KS) from Peru, we 
characterized HHV-8 in 25 KS biopsy samples. Our ﬁ  ndings 
of 8 A, 1 B, 14 C, and 2 E subtypes showed high HHV-8 
diversity in these patients and association between E geno-
type and KS development.
H
uman herpesvirus 8 (HHV-8; also known as Kaposi 
sarcoma–associated herpesvirus) is the etiologic agent 
of all forms of Kaposi sarcoma (KS) (1,2). In 2002, the 
number of KS cases worldwide was ≈65,000, nearly 1% of 
all diagnosed cancer cases (3). KS occurs commonly dur-
ing HIV-1 infection (AIDS-KS); in transplant recipients; 
and in persons not infected with HIV, predominantly elder-
ly men of Mediterranean and Middle Eastern origin (classic 
KS) or in children and adult men from eastern and Central 
Africa (endemic KS).
Sequence analysis of the highly variable open reading 
frame (ORF) K1 of HHV-8 has enabled the identiﬁ  cation 
of 5 main HHV-8 molecular subtypes, A–E (4). A and C 
subtypes are prevalent in Europe, Mediterranean countries, 
the United States, northwestern People’s Republic of Chi-
na, and southern Siberia; subtype B, in sub-Saharan Africa; 
and subtype D, in Japan and Oceania. Subtype E is found 
among Native Americans (5–9). To our knowledge, KS has 
been reported in patients infected by all HHV-8 subtypes, 
except E.
Recent studies demonstrated that classic KS is com-
mon in Peru and that AIDS-KS incidence is increasing be-
cause of the spread of HIV infection (10,11). Classic and 
epidemic KS occurred in patients of Amerindian origin 
(Quechuas) and in mestizos, reﬂ  ecting the multiethnic ori-
gin of the Peruvian population.
A goal of our study was to determine the HHV-8 geno-
types for a series of classic KS or AIDS-KS cases in Peru. 
We also aimed to report KS in patients infected by an E 
subtype.
The Study
We studied a series of 36 KS tumors diagnosed during 
1989–2002 at the Hospital Nacional Cayetano Heredia in 
Lima. All these formalin-ﬁ  xed, parafﬁ  n-embedded biopsy 
samples were stained by using hematoxylin–eosin stain and 
Perl methods. Immunohistochemistry was performed on de-
parafﬁ  nized sections by using monoclonal antibodies direct-
ed against CD34 and latent nuclear antigen (LANA-1) (12).
DNA was extracted from parafﬁ  n blocks by using the 
QIAamp DNA Mini Kit (QIAGEN GmbH, Hilden, Ger-
many). HHV-8 infection was determined by nested PCR 
to obtain a 220-bp (variable region [VR] 1–inner fragment) 
and a 240–300-bp (VR2-inner) fragment of the ORF-K1 
(13). Phylogenetic trees were generated with the neighbor-
joining method (PAUP* version 4.0b10; http://paup.csit.
fsu.edu) on fragments of either 309 bp (VR1-outer) or 
165 bp (VR1-inner) of the VR1 (K1 gene) by using differ-
ent sequence prototypes of the 4 major HHV-8 genotypes 
(13,14).
Histopathologic analysis was originally conducted 
on 36 biopsy samples, mostly from skin, diagnosed as 
KS. Three patterns were observed by hematoxylin–eosin 
stained specimens. The ﬁ  rst was characterized by dilated, 
irregular, and angulated blood vessels in the dermis, associ-
ated with a variable number of lymphocytes. In the second 
pattern, dermal vascular channels lined by plump spindle 
cells were seen; some of these spindle cells coalesced to 
form aggregates, which were poorly delineated and often 
located around blood vessels. The third pattern (nearly half 
of all biopsy samples) was characterized by well-delineat-
ed sheets and bundles of spindle cells, which coalesced to 
form nodules. The proportion of spindle cells labeled with 
the monoclonal antibody LANA-1 varied according to the 
histopathologic pattern; the bundles and sheets of spindle 
cells in the third pattern displayed the strongest signal 
(Figure 1, panel A).
DNA was extracted from the 36 formalin-ﬁ  xed, par-
afﬁ  n-embedded biopsy samples; DNA quantity and qual-
ity were appropriate in 30 biopsy samples. A faint PCR 
signal of the expected size was seen after single PCR in 
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1These authors contributed equally to this article.12 samples for VR1 (VR1-outer) and in 4 cases for VR2 
(VR2-outer) ampliﬁ   cation. After nested PCR, a signal 
was obtained in 25 cases for VR1-inner and in 17 cases 
for VR2-inner (online Appendix Table, www.cdc.gov/eid/
content/16/9/1459-TechApp.htm). After cloning and se-
quencing procedures, the HHV-8 genotype was obtained 
for 25 different KS cases, of which 8 genotypes belonged 
to the A subtype, including an A5, and 14 belonged to 
the C subtype. An E subtype was identiﬁ  ed for 2 patients. 
In 1 case, a B subtype was determined. Among these 25 
sequences, 16 were unique and 9 formed 3 groups of iden-
tical sequences. The 25 VR1-inner sequences exhibited 
0%–24.4% nt divergence and 0%–43.1% aa acid diver-
gence among pairwise comparisons. When the VR1-outer 
and VR2-inner sequences (536 bp) of the 2 E subtype 
strains in Peru were combined, the nucleotide divergence 
was ≈7% and reached 10% at the amino acid level. The 
04480 and 06772 E subtype strains were closer to the Bra-
zilian Amerindian strains (Kat, Sio, Wai, Tir, Tupi) than 
to the Ecuadorian (Hua1, Hua2, Hua3) or French Guianan 
Amerindian (Wagu) strains.
Phylogenetic analyses were performed by using 2 
sets of sequences; 25 VR1-inner (Figure 2) and 11 VR1-
outer sequences (data not shown). Forty-seven prototype 
strain sequences were added. The main molecular HHV-8 
subtypes, A–E, were identiﬁ  ed on the basis of consistent 
topology and bootstrap values obtained (Figure 2; data 
are not shown for other phylogenetic analyses performed, 
for example with the 11 VR1-outer sequences obtained 
after the ﬁ  rst round of PCR). Among the 25 VR1-inner 
sequences, 22/25 were located in the large A/C subtype, 
and 8 strains belong to the A subtype, with strains scat-
tered among 3 different subgroups (Figure 2). The 06758 
strain belongs to the typical sub-Saharan A5 group. Four-
teen strains are distributed among different groups in the 
C subtype, and the remaining sequences clustered in the 
sub-Saharan African B (04489) and Amerindian E (06772 
and 04480) subtypes.
Two AIDS-KS mestizo patients (Figure 1) were thus 
found to be infected by typical E subtype HHV-8 strains: 
a 51-year-old man with a tumor on his neck and a 24-year-
old man with multiple tumors on the upper limbs. These 
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Figure 1. Histologic patterns of cutaneous Kaposi sarcoma (KS) associated with a human herpesvirus 8 (HHV-8) type E infection. Patient 1: 
A) The spindle cells were organized as bundles, forming vascular slit-like spaces containing erythrocytes. Some macrophages containing 
hemosiderin were observed (data not shown). C) Immunohistochemical testing showed a positive signal for HHV-8 infection (latent 
nuclear antigen [LANA-1]) and CD34 (data not shown). The Perls staining also gave highly positive results (data not shown). (Patient 
1 corresponds to the ﬁ  rst patient [04/0480] in the online Appendix Table (www.cdc.gov/eid/content/16/9/1459-appT.htm), a 51-year-old 
mestizo man who had HIV-1 infection. Patient 2: B) Spindle cells forming rare vascular channels, with numerous lymphocytes, plasma 
cells, and macrophages. D) Immunohistochemistry showed a lower positive signal for HHV-8 infection (LANA-1) and CD34 (data not 
shown). Few cells displayed a positive Perls staining (data not shown). (Patient 2 corresponds to the tenth patient [06/0772] in the online 
Appendix Table, a 24-year-old mestizo man with HIV-1 infection.) Human Herpesvirus 8 Genotype E, Peru
tumors were mostly macroscopic nodules but displayed 
major histologic differences (Figure 1). CD34 (data not 
shown) and LANA-1–positive cells (Figure 1) were noted 
in both KS biopsy samples.
Conclusions
HHV-8 K1 gene characterization of KS tumor biopsy 
samples demonstrated high molecular genotype diversity, 
including 4 of the 5 main known molecular subtypes. The 
most frequent were the A and C subtypes, typically of Eu-
ropean origin. Other patients were infected by a sub-Saha-
ran African HHV-8 genotype (1 A5 and 1 B) or by HHV-8 
genotype E strains of Amerindian origin.
Such ﬁ  ndings were not unexpected because persons 
in Peru are of many ethnicities. Indeed, the genetic back-
ground of the Peruvian population is diverse, reﬂ  ecting the 
multiple waves or populations that colonized the country 
during the last millennium. Schematically, this began with 
different Amerindians groups in the Lithic period (infected 
possibly with E subtype), followed by the Spanish coloni-
zation of the Americas mainly from southern Europe (in-
fected possibly by A and C subtypes) and later slave trade 
from Africa (infected by A5 or B subtypes). Such HHV-8 
strain diversity has been previously observed in French 
Guiana (6,14).
HHV-8 genotype E previously has been found exclu-
sively in Amerindians from Central and South America, in-
cluding Brazil (5,9), Ecuador (7), and French Guiana (6). In 
each instance, HHV-8 was detected in blood samples, and 
there was some debate about the presence/development of 
KS in such highly infected populations (15).
We demonstrated that KS can occur in HHV-8 subtype 
E–infected persons. Indeed, in 2 AIDS-KS patients, an E 
genotype was characterized in the tumor lesions. Further 
studies are ongoing to provide new insights into the distri-
bution and genetic epidemiology of such HHV-8 infection 
in Amerindian populations.
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